The main aspects of ademetionine administration in the early stages of the experiment in the correction of streptozotocin-induced diabetes mellitus with the characteristics of the presence and topography of lipid inclusions in the liver
DOI:
https://doi.org/10.26641/1997-9665.2023.3.36-39Keywords:
liver, streptozotocin diabetes, diabetic hepatopathies, experimental research.Abstract
Background. The basis of the morphological changes of the liver in diabetes is the accumulation of fatty inclusions with the subsequent development of non-alcoholic fatty liver disease, which leads to insulin resistance. Hepatoprotective therapy allows these negative interrelated processes to be eliminated. Ademethionine (Heptral) is effective for such changes. Objective: to establish the main aspects of ademetionine administration after 14 and 28 days of the experiment with the assessment of the presence, possible dynamics and topography of fatty inclusions in the liver of rats with streptozotocin diabetes and its correction. Methods. 40 sexually mature male Wistar rats weighing 150-190 g were divided into 3 groups: I - 4 intact; II - includes 3 subgroups of 10 rats with simulated streptozotocin diabetes (with streptozotocin "Sigma", USA): 2A - without treatment; 2B – insulin correction from the 14th day; 2C - insulin and ademethionine were administered from the 14th day; III - 6 control. Results. In subgroup 2A, diffuse small vacuole lipid inclusions appear after 14 days. Topographically, they are most in zona intermedia (II) and peripherica (I). Zona centralis (ІІІ) is practicaly free. On the 28th day, a significant increase in the number of fat droplets is noted in subgroup 2A. There are massive small- and medium-caliber , sometimes of a showery nature in zones II and I. Zona ІІІ - small and isolated medium-caliber inclusions. There are significantly fewer inclusions in subgroup 2B; single small droplets, most in zone II. In subgroup 2C are practically no fatty inclusions. Conclusion. The optimal starting dose of ademetionine for the correction of decompensated diabetes is 4 mg/kg of body weight per day. It is not recommended 12 mg/kg. Maintenance - 8 mg/kg, in which the level of lipid inclusions corresponded to the norm.
References
- Abraham D, author. Updated Diabetes Eradication book. 10th Edition. UK: Independently Published; 2021. 72 p.
- Tkachuk OV, Tkachuk SS, Povar MA, Boshtan SV, Sorokhan VD. [Pathogenesis of the morphofunctional state of the liver in type 1 diabetes mellitus]. Klinichna ta eksperymentalna patolohiia. 2020;19(2(72)):98-101. Ukrainian.
- Skrypnyk NV. [Pathogenetic justification of hepatoprotective therapy in patients with diabetes]. Mizhnarodnyi endokrynolohichnyi zhurnal. 2014;6(62):85-90. Ukrainian.
- Fediv OI, Marchuk YuF, Voloshyna LO. [Peculiarities of lesions of the hepatobiliary system in patients with type II diabetes]. Bukovynskyi medychnyi visnyk. 2008;12(4):126-130. Ukrainian.
- Anstee QA, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility. Journal of Hepatology. 2012;57(5):1097-1109.
- Levytskyi VA, Zhurakivska OIa, Miskiv VA, Zaiats LM, Petriv RB, Yakymiv YuM, Hnatiuk RZ, inventors; Levytskyi VA, Zhurakivska OIa, Miskiv VA, Zaiats LM, Petriv RB, Yakymiv YuM, Hnatiuk RZ, assignee. The method of modeling diabetes type 1 in animals of different ages. Ukrainian patent UA 201101566. 2011 Sep 26. Ukrainian.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world.
The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.
